“SEEMS Corporation is engaged in adipose-derived mesenchymal stem cell (ASC) and regenerative medicine, serum-free medium development, and disease research. Its areas of activity include: research to clarify efficient culture methods, safety, effectiveness, and action mechanisms to ASCs; safety verification of serum-free medium; three-dimensional differentiation; development of quality markers; analysis of secretory substances.”

SEEMS's challenge

Message

SEEMS R&D has been involved in research on efficient cultural methods, safety, effectiveness, and action mechanisms of adipose-derived stem cells (ASCs), using self-developed serum-free medium. Since the 2000s, there have been a variety of research findings on the basic properties of ASCs. In this regard, among other types of stem cells, ASCs have attracted attention for its easily extractable, highly safe, and broadly applicable properties, as a key to regenerative medicine in the future.

News Release

  • メディア情報

    8th Conference of the Japan Society of Aesthetic and Anti-Aging

    8th Conference of the Japan Society of Aesthetic and An …

    Read more...

  • 論文情報

    Potential of Alzheimer’s disease treatment by stem cells

    Read more...

  • プレス情報

    Warning relating to the solicitation of any offer to purchase our stocks

    As for shares of SEEMS stock, we have received reports …

    Read more...

  • 学会情報

    8th Conference of the Japan Society of Aesthetic and Anti-Aging

    8th Conference of the Japan Society of Aesthetic and An …

    Read more...